Cargando…
Efficacy of Combined Abelmoschus manihot and Irbesartan for Reduction of Albuminuria in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter Randomized Double-Blind Parallel Controlled Clinical Trial
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274216/ https://www.ncbi.nlm.nih.gov/pubmed/35613364 http://dx.doi.org/10.2337/dc22-0607 |
| _version_ | 1784745259560861696 |
|---|---|
| author | Zhao, Jing Tostivint, Isabelle Xu, Lingdong Huang, Jihan Gambotti, Laetitia Boffa, Jean-Jacques Yang, Min Wang, Ling Sun, Zhuxing Chen, Xiaolan Liou-Schischmanoff, Amélie Baumelou, Alain Ma, Teng Lu, Guoyuan Li, Ling Chen, Dai Piéroni, Laurence Liu, Bingkai Qin, Xiao He, Weiming Wang, Yuejuan Gu, Harvest F. Sun, Wei |
| author_facet | Zhao, Jing Tostivint, Isabelle Xu, Lingdong Huang, Jihan Gambotti, Laetitia Boffa, Jean-Jacques Yang, Min Wang, Ling Sun, Zhuxing Chen, Xiaolan Liou-Schischmanoff, Amélie Baumelou, Alain Ma, Teng Lu, Guoyuan Li, Ling Chen, Dai Piéroni, Laurence Liu, Bingkai Qin, Xiao He, Weiming Wang, Yuejuan Gu, Harvest F. Sun, Wei |
| author_sort | Zhao, Jing |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9274216 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92742162022-07-28 Efficacy of Combined Abelmoschus manihot and Irbesartan for Reduction of Albuminuria in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter Randomized Double-Blind Parallel Controlled Clinical Trial Zhao, Jing Tostivint, Isabelle Xu, Lingdong Huang, Jihan Gambotti, Laetitia Boffa, Jean-Jacques Yang, Min Wang, Ling Sun, Zhuxing Chen, Xiaolan Liou-Schischmanoff, Amélie Baumelou, Alain Ma, Teng Lu, Guoyuan Li, Ling Chen, Dai Piéroni, Laurence Liu, Bingkai Qin, Xiao He, Weiming Wang, Yuejuan Gu, Harvest F. Sun, Wei Diabetes Care e-Letters: Observations American Diabetes Association 2022-07-07 2022-05-25 /pmc/articles/PMC9274216/ /pubmed/35613364 http://dx.doi.org/10.2337/dc22-0607 Text en © 2022 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license. |
| spellingShingle | e-Letters: Observations Zhao, Jing Tostivint, Isabelle Xu, Lingdong Huang, Jihan Gambotti, Laetitia Boffa, Jean-Jacques Yang, Min Wang, Ling Sun, Zhuxing Chen, Xiaolan Liou-Schischmanoff, Amélie Baumelou, Alain Ma, Teng Lu, Guoyuan Li, Ling Chen, Dai Piéroni, Laurence Liu, Bingkai Qin, Xiao He, Weiming Wang, Yuejuan Gu, Harvest F. Sun, Wei Efficacy of Combined Abelmoschus manihot and Irbesartan for Reduction of Albuminuria in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter Randomized Double-Blind Parallel Controlled Clinical Trial |
| title | Efficacy of Combined Abelmoschus manihot and Irbesartan for Reduction of Albuminuria in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter Randomized Double-Blind Parallel Controlled Clinical Trial |
| title_full | Efficacy of Combined Abelmoschus manihot and Irbesartan for Reduction of Albuminuria in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter Randomized Double-Blind Parallel Controlled Clinical Trial |
| title_fullStr | Efficacy of Combined Abelmoschus manihot and Irbesartan for Reduction of Albuminuria in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter Randomized Double-Blind Parallel Controlled Clinical Trial |
| title_full_unstemmed | Efficacy of Combined Abelmoschus manihot and Irbesartan for Reduction of Albuminuria in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter Randomized Double-Blind Parallel Controlled Clinical Trial |
| title_short | Efficacy of Combined Abelmoschus manihot and Irbesartan for Reduction of Albuminuria in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter Randomized Double-Blind Parallel Controlled Clinical Trial |
| title_sort | efficacy of combined abelmoschus manihot and irbesartan for reduction of albuminuria in patients with type 2 diabetes and diabetic kidney disease: a multicenter randomized double-blind parallel controlled clinical trial |
| topic | e-Letters: Observations |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274216/ https://www.ncbi.nlm.nih.gov/pubmed/35613364 http://dx.doi.org/10.2337/dc22-0607 |
| work_keys_str_mv | AT zhaojing efficacyofcombinedabelmoschusmanihotandirbesartanforreductionofalbuminuriainpatientswithtype2diabetesanddiabetickidneydiseaseamulticenterrandomizeddoubleblindparallelcontrolledclinicaltrial AT tostivintisabelle efficacyofcombinedabelmoschusmanihotandirbesartanforreductionofalbuminuriainpatientswithtype2diabetesanddiabetickidneydiseaseamulticenterrandomizeddoubleblindparallelcontrolledclinicaltrial AT xulingdong efficacyofcombinedabelmoschusmanihotandirbesartanforreductionofalbuminuriainpatientswithtype2diabetesanddiabetickidneydiseaseamulticenterrandomizeddoubleblindparallelcontrolledclinicaltrial AT huangjihan efficacyofcombinedabelmoschusmanihotandirbesartanforreductionofalbuminuriainpatientswithtype2diabetesanddiabetickidneydiseaseamulticenterrandomizeddoubleblindparallelcontrolledclinicaltrial AT gambottilaetitia efficacyofcombinedabelmoschusmanihotandirbesartanforreductionofalbuminuriainpatientswithtype2diabetesanddiabetickidneydiseaseamulticenterrandomizeddoubleblindparallelcontrolledclinicaltrial AT boffajeanjacques efficacyofcombinedabelmoschusmanihotandirbesartanforreductionofalbuminuriainpatientswithtype2diabetesanddiabetickidneydiseaseamulticenterrandomizeddoubleblindparallelcontrolledclinicaltrial AT yangmin efficacyofcombinedabelmoschusmanihotandirbesartanforreductionofalbuminuriainpatientswithtype2diabetesanddiabetickidneydiseaseamulticenterrandomizeddoubleblindparallelcontrolledclinicaltrial AT wangling efficacyofcombinedabelmoschusmanihotandirbesartanforreductionofalbuminuriainpatientswithtype2diabetesanddiabetickidneydiseaseamulticenterrandomizeddoubleblindparallelcontrolledclinicaltrial AT sunzhuxing efficacyofcombinedabelmoschusmanihotandirbesartanforreductionofalbuminuriainpatientswithtype2diabetesanddiabetickidneydiseaseamulticenterrandomizeddoubleblindparallelcontrolledclinicaltrial AT chenxiaolan efficacyofcombinedabelmoschusmanihotandirbesartanforreductionofalbuminuriainpatientswithtype2diabetesanddiabetickidneydiseaseamulticenterrandomizeddoubleblindparallelcontrolledclinicaltrial AT liouschischmanoffamelie efficacyofcombinedabelmoschusmanihotandirbesartanforreductionofalbuminuriainpatientswithtype2diabetesanddiabetickidneydiseaseamulticenterrandomizeddoubleblindparallelcontrolledclinicaltrial AT baumeloualain efficacyofcombinedabelmoschusmanihotandirbesartanforreductionofalbuminuriainpatientswithtype2diabetesanddiabetickidneydiseaseamulticenterrandomizeddoubleblindparallelcontrolledclinicaltrial AT mateng efficacyofcombinedabelmoschusmanihotandirbesartanforreductionofalbuminuriainpatientswithtype2diabetesanddiabetickidneydiseaseamulticenterrandomizeddoubleblindparallelcontrolledclinicaltrial AT luguoyuan efficacyofcombinedabelmoschusmanihotandirbesartanforreductionofalbuminuriainpatientswithtype2diabetesanddiabetickidneydiseaseamulticenterrandomizeddoubleblindparallelcontrolledclinicaltrial AT liling efficacyofcombinedabelmoschusmanihotandirbesartanforreductionofalbuminuriainpatientswithtype2diabetesanddiabetickidneydiseaseamulticenterrandomizeddoubleblindparallelcontrolledclinicaltrial AT chendai efficacyofcombinedabelmoschusmanihotandirbesartanforreductionofalbuminuriainpatientswithtype2diabetesanddiabetickidneydiseaseamulticenterrandomizeddoubleblindparallelcontrolledclinicaltrial AT pieronilaurence efficacyofcombinedabelmoschusmanihotandirbesartanforreductionofalbuminuriainpatientswithtype2diabetesanddiabetickidneydiseaseamulticenterrandomizeddoubleblindparallelcontrolledclinicaltrial AT liubingkai efficacyofcombinedabelmoschusmanihotandirbesartanforreductionofalbuminuriainpatientswithtype2diabetesanddiabetickidneydiseaseamulticenterrandomizeddoubleblindparallelcontrolledclinicaltrial AT qinxiao efficacyofcombinedabelmoschusmanihotandirbesartanforreductionofalbuminuriainpatientswithtype2diabetesanddiabetickidneydiseaseamulticenterrandomizeddoubleblindparallelcontrolledclinicaltrial AT heweiming efficacyofcombinedabelmoschusmanihotandirbesartanforreductionofalbuminuriainpatientswithtype2diabetesanddiabetickidneydiseaseamulticenterrandomizeddoubleblindparallelcontrolledclinicaltrial AT wangyuejuan efficacyofcombinedabelmoschusmanihotandirbesartanforreductionofalbuminuriainpatientswithtype2diabetesanddiabetickidneydiseaseamulticenterrandomizeddoubleblindparallelcontrolledclinicaltrial AT guharvestf efficacyofcombinedabelmoschusmanihotandirbesartanforreductionofalbuminuriainpatientswithtype2diabetesanddiabetickidneydiseaseamulticenterrandomizeddoubleblindparallelcontrolledclinicaltrial AT sunwei efficacyofcombinedabelmoschusmanihotandirbesartanforreductionofalbuminuriainpatientswithtype2diabetesanddiabetickidneydiseaseamulticenterrandomizeddoubleblindparallelcontrolledclinicaltrial |